CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-08 | Broadrick Dale 10% owner | Purchase | +61,971 | $0.13 | $8K | 4,009,399 |
| 2019-10-08 | Broadrick Dale 10% owner | Purchase | +14,000 | $0.14 | $2K | 4,023,399 |
| 2019-09-09 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +100 | $0.22 | $22 | 30,100 |
| 2019-09-09 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +2,500 | $0.23 | $575 | 32,600 |
| 2019-09-09 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +2,500 | $0.24 | $600 | 35,100 |
| 2019-09-09 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +14,900 | $0.27 | $4K | 50,000 |
| 2019-09-06 | Weinreb Mark CEO and Chairman of the Board | Purchase | +5,500 | $0.24 | $1K | 110,500 |
| 2019-09-06 | Weinreb Mark CEO and Chairman of the Board | Purchase | +2,500 | $0.24 | $591 | 113,000 |
| 2019-09-06 | Weinreb Mark CEO and Chairman of the Board | Purchase | +4,000 | $0.23 | $920 | 117,000 |
| 2019-09-05 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +100 | $0.25 | $25 | 20,100 |
| 2019-09-05 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +9,900 | $0.27 | $3K | 30,000 |
| 2019-09-05 | Weinreb Mark CEO and Chairman of the Board | Purchase | +10,000 | $0.27 | $3K | 105,000 |
| 2019-09-04 | Silva Francisco VP of Research and Development | Purchase | +2,500 | $0.24 | $589 | 37,503 |
| 2019-09-04 | Silva Francisco VP of Research and Development | Purchase | +18,455 | $0.24 | $4K | 55,958 |
| 2019-08-30 | Silva Francisco VP of Research and Development | Purchase | +2,500 | $0.26 | $650 | 19,503 |
| 2019-08-30 | Silva Francisco VP of Research and Development | Purchase | +5,000 | $0.28 | $1K | 24,503 |
| 2019-08-30 | Silva Francisco VP of Research and Development | Purchase | +10,500 | $0.28 | $3K | 35,003 |
| 2019-08-29 | Tonna Paul Jude Director | Purchase | +17,850 | $0.28 | $5K | 123,850 |
| 2019-08-29 | Weinreb Mark CEO and Chairman of the Board | Purchase | +2,500 | $0.26 | $658 | 92,500 |
| 2019-08-29 | Weinreb Mark CEO and Chairman of the Board | Purchase | +2,500 | $0.27 | $675 | 95,000 |
Page 12 of 35 · 690 trades